Despite industry concerns, genetic testing kits hit the market
Contemporary Long-Term Care Weekly, May 13, 2010
On May 14, the first major U.S. retail chain will begin selling genetic testing kits. Insight personal genetic testing kits, manufactured by Pathway Genomics, aim to assess an individual’s risk of developing a number of health conditions, including Alzheimer’s disease, cancer, and obesity, by screening for genetic markers. Priced at $20 to $30, the kit includes a vial and a shipping envelope. Consumers send a saliva sample to Pathway, which posts results online. Depending on the test type, the online report costs anywhere from $79 to $179, according to the Chicago Tribune.
Pathway insists that the test meets all federal regulations. Nonetheless, the Food and Drug Administration (FDA) is looking into the medical claims made in the product’s marketing material. Scientists, bio-ethicists, and genetic counselors have expressed concerns over personal genetic testing. Many fear that consumers will misunderstand the test’s results because they are so open to interpretation. Consumers are encouraged to discuss their results with a genetic counselor or doctor.
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- HIPAA Q&A: Level of encryption needed for email
- Searched
